{
    "2019-01-08": [
        [
            {
                "time": "2019-01-08",
                "original_text": "Eli Lilly giving price info on advertised drugs via website",
                "features": {
                    "keywords": [
                        "price info",
                        "advertised drugs",
                        "website"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Why Eli Lilly Is Buying Loxo Oncology for $8 Billion",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Loxo Oncology",
                        "$8 Billion",
                        "Buying"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "WEISSLAW LLP: Loxo Oncology, Inc. Acquisition May Not Be In The Best Interests of LOXO Shareholders",
                "features": {
                    "keywords": [
                        "WEISSLAW LLP",
                        "Loxo Oncology",
                        "Acquisition",
                        "Shareholders"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Crowded Cancer Space Triggers Big M&A Deals: More in Store?",
                "features": {
                    "keywords": [
                        "Cancer",
                        "M&A Deals",
                        "Big"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo",
                "features": {
                    "keywords": [
                        "Lilly",
                        "$8B",
                        "Acquire",
                        "Cancer-Focused",
                        "Biotech",
                        "Loxo"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "LLY",
                        "Momentum Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Loxo Oncology Is Expected to Boost Eli Lillyâ€™s Revenue in 2019",
                "features": {
                    "keywords": [
                        "Loxo Oncology",
                        "Boost",
                        "Eli Lilly",
                        "Revenue",
                        "2019"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "cut",
                        "jobs",
                        "France",
                        "voluntary redundancy"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}